Doctor's Bio
Dr. Lauren Postlewait, MD, FACS, is a board-certified breast surgeon who specializes in caring for patients with breast cancer and breast conditions. She leads the Breast Center at Grady’s Cancer Center and is known for providing compassionate, team-based care.
She completed all of her medical training at Emory University and then pursued advanced fellowship training in breast surgical oncology at MD Anderson Cancer Center. Dr. Postlewait also teaches future breast surgeons and stays active in national breast cancer organizations.
Her work focuses on giving patients the best outcomes with the least amount of treatment possible, improving patient education, and reducing health disparities.
Board Certifications
American Board of Surgery
Affiliations
Emory
Education & Training
- Medical School: Emory University School of Medicine
- Internship: Emory University Hospital
- Residency: Emory University Hospital
Fellowships
University of Texas MD Anderson Cancer Center
Awards and Honors
- Atlanta's "Top Doctors" by Atlanta Magazine in 2022 and 2023
- Best Clinical Research awards at Emory University for the Department of Surgery in 2015 and 2017
- Merit Award from the Conquer Cancer Foundation of the American Society of Clinical Oncology in 2015 and 2016
- Alpha Omega Alpha at Emory University School of Medicine in 2012
- Phi Beta Kappa at the Massachusetts Institute of Technology in 2008
Locations and Directions
Correll Pavilion
Phone: (404) 616-1000
Location:
80 Gilmer St. SE
Atlanta, GA 30303
Publications
- ASO Visual Abstract: Defining the Surgical Oncology Experience During General Surgery Residency: A Multi-Institutional Study from the US ROPE Consortium.
Reagan AM, Montgomery KB, Woeste MR, Sutton JM, Smith SR, Postlewait LM, Farr D, Abelson JS, Cho NL, Foote DC, Meister KM, Lindeman B, Kimbrough MK, Nahmias J, Callahan ZM, Marks JA, Elsaadi A, Burton E, Richmond R, Dodwad SM, Adams SD, Buonpane CL, Patel P, Anstadt MJ, Nasim BW, Layne D, Jung S, Pratt CG, Quillin RC, Kim J, Patel JA, Cortez AR, Winer LK
Annals of surgical oncology. 2025;
PMID: 41247598 - Defining the Surgical Oncology Experience during General Surgery Residency: A Multi-Institutional Study from the US ROPE Consortium.
Reagan AM, Montgomery KB, Woeste MR, Sutton JM, Smith SR, Postlewait LM, Farr D, Abelson JS, Cho NL, Foote DC, Meister KM, Lindeman B, Kimbrough MK, Nahmias J, Callahan ZM, Marks JA, Elsaadi A, Burton E, Richmond R, Dodwad SM, Adams SD, Buonpane CL, Patel P, Anstadt MJ, Nasim BW, Layne D, Jung S, Pratt CG, Quillin RC, Kim J, Patel JA, Cortez AR, Winer LK
Annals of surgical oncology. 2025;
PMID: 41139184 - Impact of Time to Surgery Post Neoadjuvant Chemotherapy on Breast Cancer Outcomes: A Retrospective Study of Patients Enrolled in the I-SPY 2 Clinical Trial.
Van Hassel J, Dimitroff K, Yau C, Mukhtar R, Boughey JC, Ladores V, Howard-McNatt MM, Jaskowiak N, Perlmutter J, DeMichele A, Yee D, Hylton N, Symmans WF, Veer LV, Rugo H, Esserman LJ, Shatsky R, Isaacs C, Kuerer H, Wallace AM, Prionas N, Tseng J, Reyna CR, Taunk N, Kesmodel S, Lee MC, Fox J, Piltin MA, Tchou J, Arciero CA, Postlewait LM, Sauder C, Rao R
Annals of surgical oncology. 2025;32(11):8113-8126.
PMID: 40849380 - Characterizing the General Surgery Experience of Future Breast Surgeons: A Multi-institutional Study from the US ROPE Consortium.
Reagan AM, Jones VM, Ibrahim-Zada I, Smith SR, Postlewait LM, Farr D, Abelson JS, Cho NL, Foote DC, Meister KM, Montgomery KB, Lindeman B, Kimbrough MK, Nahmias J, Callahan ZM, Marks JA, Sutton JM, Elsaadi A, Burton E, Richmond R, Dodwad SM, Adams SD, Woeste MR, Buonpane CL, Patel P, Anstadt MJ, Nasim BW, Layne D, Jung S, Pratt CG, Quillin RC, Kim J, Patel JA, Cortez AR, Winer LK
Annals of surgical oncology. 2025;32(11):8340-8348.
PMID: 40711683 - Impact of Neoadjuvant Chemotherapy on Surgical Outcomes and Conversion to Node-Negativity in Invasive Lobular Breast Cancer: Analysis of Molecularly High-Risk Tumors by Histologic Subtype on the I-SPY2 Clinical Trial.
Mukhtar RA, Dimitroff K, Yau C, Chien AJ, Connolly EP, Howard-McNatt M, Rao R, Ladores V, Golshan M, Sauder CA, Ahmed K, Lancaster R, Fox J, Gutnik L, Lee MC, Tchou J, Prionas N, Arciero CA, Reyna C, Kuerer H, Switalla K, Taunk N, Tuttle TM, Moran MS, Postlewait LM, Perlmutter J, DeMichele A, Yee D, Hylton N, Symmans WF, Rugo HS, Shatsky R, Isaacs C, Esserman LJ, Van't Veer L, Boughey JC
Annals of surgical oncology. 2025;32(11):8243-8253.
PMID: 40705266 - Disparities in the Surgical Management of the Axilla by Self-Identified Race in the Multicenter Neoadjuvant I-SPY2 Trial.
Kaur M, Dimitroff K, Boughey JC, Esserman LJ, Yau C, Tchou J, Quirarte A, Lee MC, Howard-McNatt MM, Switalla K, Kuerer H, Sauder C, Postlewait LM, Arciero C, Rao R, Wallace A, Reyna C, Ahmed K, Gutnik L, Taunk N, Perlmutter J, DeMichele A, Yee D, Hylton NM, Symmans WF, Rugo HS, Shatsky RA, Isaacs C, Rudra S, Pohlmann P, Ewing C, Wong J, Alvarado M, Jaskowiak N, Prionas N, Golshan M, Piltin MA, Olopade OI, Mukhtar RA
Annals of surgical oncology. 2025;32(11):8211-8219.
PMID: 40699532 - Postmastectomy Radiation Therapy for Intermediate-Risk Breast Cancer Patients With 0-3 Positive Axillary Lymph Nodes: Emulating the SUPREMO Trial Using Real-World Data.
Kulkarni SE, Patel SA, Jiang C, Schwieger L, Postlewait LM, Arciero CA, Gillespie TW, Liu Y
Clinical breast cancer. 2025;25(5):e655-e665.e4.
PMID: 40187907 - The prevalence and clinical significance of residual occult breast cancer after neoadjuvant chemotherapy: reassessing surgical pathology in cases initially described as pathological complete response.
Ai D, Arrey EN, Postlewait LM, Gao Y, Li X
Histopathology. 2025;86(7):1112-1120.
PMID: 39904575 - Defining the Need for Services for Patients at High Risk of Breast Cancer at a Safety-Net Hospital: An Approach to Narrowing the Disparities Gap.
Cheng O, Fiser C, Paysour J, Aluwalia R, Hilliard A, Arciero C, Farley CR, Jones J, Conyers J, Postlewait LM
Annals of surgical oncology. 2024;31(11):7570-7581.
PMID: 39138769 - ASO Author Reflections: Defining the Need for Services for Patients at High Risk of Breast Cancer at a Safety-Net Hospital: An Approach to Narrowing the Disparities Gap.
Cheng O, Postlewait LM
Annals of surgical oncology. 2024;31(13):8910-8911.
PMID: 39068321
PLANNING
PREPARING FOR YOUR VISIT
Whether you’re a patient or you’re visiting one, a little planning beforehand can make your visit to Grady easier and more comfortable. Here, you’ll find everything you need to prepare for your visit, including an appointment checklist, admissions information, dining options, and much more.